DAVID GRAHAM to Pilot Projects
This is a "connection" page, showing publications DAVID GRAHAM has written about Pilot Projects.
Connection Strength
0.970
-
Mechanical colon cleansing for screening colonoscopy: A randomized controlled trial. J Dig Dis. 2017 Dec; 18(12):691-697.
Score: 0.101
-
Tissue resonance interaction accurately detects colon lesions: A double-blind pilot study. World J Gastroenterol. 2015 Jul 07; 21(25):7851-9.
Score: 0.086
-
High-dose extended-release lansoprazole (dexlansoprazole) and amoxicillin dual therapy for Helicobacter pylori infections. Helicobacter. 2014 Aug; 19(4):319-22.
Score: 0.078
-
Lactobacillus reuteri in the treatment of Helicobacter pylori infection. Intern Emerg Med. 2014 Sep; 9(6):649-54.
Score: 0.076
-
Greater than 95% success with 14-day bismuth quadruple anti- Helicobacter pylori therapy: a pilot study in US Hispanics. Helicobacter. 2012 Oct; 17(5):382-90.
Score: 0.069
-
Increasing the duration of dual amoxicillin plus omeprazole Helicobacter pylori eradication to 6 weeks: a pilot study. J Gastroenterol Hepatol. 2012 Jan; 27(1):59-61.
Score: 0.067
-
Dual proton pump inhibitor plus amoxicillin as an empiric anti-H. pylori therapy: studies from the United States. J Gastroenterol. 2010 Aug; 45(8):816-20.
Score: 0.059
-
Randomized, double-blind, pilot study of geranylgeranylacetone versus placebo in patients taking low-dose enteric-coated aspirin. Low-dose aspirin-induced small bowel damage. Scand J Gastroenterol. 2010 Mar; 45(3):292-8.
Score: 0.059
-
Sequential therapy using high-dose esomeprazole-amoxicillin followed by gatifloxacin for Helicobacter pylori infection. Aliment Pharmacol Ther. 2006 Sep 01; 24(5):845-50.
Score: 0.046
-
Effect of the carbonic anhydrase inhibitor, acetazolamide, on Helicobacter pylori infection in vivo: a pilot study. Helicobacter. 2005 Apr; 10(2):136-8.
Score: 0.042
-
Novel bismuth-metronidazole-tetracycline triple-layer tablet for treatment of Helicobacter pylori. Aliment Pharmacol Ther. 2005 Jan 15; 21(2):165-8.
Score: 0.041
-
Twice daily (mid-day and evening) quadruple therapy for H. pylori infection in the United States. Dig Liver Dis. 2004 Jun; 36(6):384-7.
Score: 0.040
-
A pilot study evaluating high dose esomeprazole, bismuth subcitrate and amoxicillin for eradicating Helicobacter pylori infection in Iran. Helicobacter. 2024 Jan-Feb; 29(1):e13061.
Score: 0.039
-
Pilot studies of vonoprazan-containing Helicobacter pylori eradication therapy suggest Thailand may be more similar to the US than Japan. Helicobacter. 2023 Dec; 28(6):e13019.
Score: 0.038
-
Twice-a-day PPI, tetracycline, metronidazole quadruple therapy with Pylera? or Lactobacillus reuteri for treatment na?ve or for retreatment of Helicobacter pylori. Two randomized pilot studies. Helicobacter. 2019 Dec; 24(6):e12659.
Score: 0.029
-
Comparison of two multiband mucosectomy devices for endoscopic resection of Barrett's esophagus-related neoplasia. Surg Endosc. 2019 11; 33(11):3665-3672.
Score: 0.027
-
Feasibility of shortening 14-day hybrid therapy while maintaining an excellent Helicobacter pylori eradication rate. Helicobacter. 2014 Jun; 19(3):207-13.
Score: 0.020
-
Effect of fluoroquinolone resistance on 14-day levofloxacin triple and triple plus bismuth quadruple therapy. Helicobacter. 2013 Oct; 18(5):373-7.
Score: 0.018
-
Evaluation of a novel stool native catalase antigen test for Helicobacter pylori infection in asymptomatic North American children. J Pediatr Gastroenterol Nutr. 2008 Apr; 46(4):399-402.
Score: 0.013
-
Rabeprazole containing triple therapy to eradicate Helicobacter pylori infection on the Texas-Mexican border. Aliment Pharmacol Ther. 2006 Jan 15; 23(2):295-301.
Score: 0.011
-
A pilot study of Helicobacter pylori infection and risk of laryngopharyngeal cancer. Head Neck. 2005 Jan; 27(1):22-7.
Score: 0.010